PRODUCT DETAILS
Composition
Contains:
- Latanoprost 0.005%
- Timolol maleate 0.5% (drugs.com)
Category / Class
- Combination anti-glaucoma eye drop
- Prostaglandin analogue + beta-blocker ophthalmic preparation
Use / Indications
Used for:
- Open-angle glaucoma
- Ocular hypertension
- Patients insufficiently controlled with single glaucoma medication (drugs.com)
Mechanism of Action
- Latanoprost increases aqueous humour outflow from the eye.
- Timolol decreases aqueous humour production.
Together they reduce intraocular pressure more effectively than either medicine alone.
Direction of Use
Typical dosage:
- 1 drop into affected eye(s) once daily
Instructions:
- Preferably use in the evening
- Wash hands before use
- Avoid touching dropper tip
- Remove contact lenses before instillation
- Reinsert contact lenses after at least 15 minutes
- If using other eye drops, wait at least 5 minutes between medications
Common Side Effects
Eye-related:
- Eye redness
- Burning/stinging
- Blurred vision
- Eye irritation
- Dry eyes
- Increased eyelash growth
- Darkening of iris or eyelids
Systemic (timolol-related):
- Slow heart rate
- Fatigue
- Dizziness
- Shortness of breath
Serious Side Effects
Seek urgent medical attention if patient develops:
- Wheezing or breathing difficulty
- Chest pain
- Severe dizziness/fainting
- Severe allergic reaction
- Significant vision changes
- Severe eye pain/swelling
- Heart rhythm disturbances
Warnings
Do NOT use in:
- Asthma or severe COPD
- Sinus bradycardia
- Heart block
- Heart failure
- Allergy to latanoprost or timolol
- Severe respiratory disease
Important warnings:
- Timolol may be systemically absorbed and act like oral beta-blockers
- Iris colour change may be permanent
- May mask signs of hypoglycaemia in diabetics
- Use cautiously in thyroid disease
Drug Interactions
Use cautiously with:
- Oral beta-blockers
- Calcium channel blockers
- Digoxin
- Antiarrhythmics
- Other glaucoma drops
- Insulin/antidiabetic medicines
- CYP2D6 inhibitors (e.g., fluoxetine, quinidine)
Cautions
- Perform punctal occlusion (close eyes gently after instillation) to reduce systemic absorption
- Temporary blurred vision may impair driving
- Monitor pulse and breathing in susceptible patients
- Use cautiously in:
- Diabetes
- Heart disease
- Respiratory disease
- Peripheral vascular disease
- Store according to manufacturer instructions